The MERLN institute is dedicated to advancing research across a range of disciplines, including biomaterials, biofabrication, micro- and nanofabrication, cell biology, and in silico approaches for regenerative medicine. To help guide our efforts and ensure that we are operating in a sustainable and strategic manner, we have established an International Scientific Advisory Board (ISAB). The ISAB is composed of five independent advisors who provide expertise in areas such as scientific development and technical guidance, as well as strategic planning and industry partnerships. With input from the ISAB, we aim to continue building upon MERLN's core strengths of technology-based research, translation to the clinic, and collaboration with industry partners. The ISAB ensures that te strategic vision of MERLN is reviewed on an annual basis with appropriate international input and benchmarking.